Brief: Guerbet Signs New Agreement With IBM Watson Health On AI Solution
Sept 24 (Reuters) - GUERBET SA GRBT.PA :
* SIGNED A NEW AGREEMENT WITH IBM WATSON HEALTH TO
CO-DEVELOP AND
CO-COMMERCIALIZE AN AI SOLUTION
* THIS SECOND AGREEMENT IS AIMED AT DEVELOPING AND MARKETING
A
SOFTWARE SOLUTION TO HELP RADIOLOGISTS AND ONCOLOGISTS DIAGNOSE
AND MONITOR PROSTATE CANCER
Source text for Eikon: ID:nPn3Klycga
Further company coverage: GRBT.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Guerbet SA
See all newsBrief: Guerbet Q1 Revenue At EUR 177.4 Mln
Guerbet Q1 revenue up 2.6% at CER on increased volumes in EMEA and Asia
Medical imaging firm Guerbet's 2025 revenue falls on lower sales activity in France
Brief: Guerbet Says FDA Approves Labeling Update For Guerbet's Elucirem Injection
France's Guerbet misses 2025 revenue estimates